Behavioral Health Staff: Medical & Pharmacy
BHRS Medical & Pharmacy Information
BHRS Policies & Forms
  Link to BHRS
  Policies & Forms
  Avatar Instructions to find HEALTHsuite Number (HSN)
  Medication Monitoring Policy
  Medication Monitoring Checklist--fillable
  BHRS FDA Guidelines for Indications and Dosage Ranges
   
Laboratory References
  Lab Guide
  CBC non-included MH Dx
  HBA1c NCD Dx
  HCG test NCD Dx
  LabCorp Drugs of Abuse Testing LCD
  LCD for MolDx HLA-B* 15 02 Genetic Testing
  Lipid Panel NCD Dx
  Medi-Cal Dx for Vitamin B12
  Prolactin ICD10 codes CA MediCal
  Pharmacogenetic Test Protocol and Request
  Thyroid Test NCD Dx
  Vitamin D 25 hydroxy
Medication and Assessment Forms
  AIM SCALE
  Brief Psychiatric Rating Scale (BPRS)
  Lab Weight Chart
  Montreal Cognitive Assessment (MOCA)
  
  
Prescribing References
  Atypical Antipsychotic LAI Comparison
  BHRS Formulary
  BHRS PA Procedures and Criteria
  CareAdvantage Prior Authorization Form
  Clozapine Guidelines
  Clozapine Flowchart
  Management of Neuropsychiatric Symptoms in Dementia
  Medi-Cal Covered Drug List (CDL) for Psychotropics
  MediCal Rx -- 5 ways to submit PA
  MediCal Rx Prior Authorization Form
  Methadone and QTc Prolongation 
  Psychotropics Available in Liquid or ODT formulations
Treatment Guidelines
ADHD/Stimulants
  ADHD Medications
  ADHD Protocol for Adults seeking services at BHRS
  Adult ADHD Treatment Guidelines
  Controlled Medication Agreement – EnglishSpanish
  Controlled Medication Guidelines
Benzodiazepines/Hypnotics
  Alternatives to Benzodiazepines in Insomnia/Anxiety
  Benzodiazepines Client Education Sheet – English
  Spanish
  Benzodiazepines Dosing & PK
  Benzodiazepines and Z Drugs Guidelines
  Controlled Medication Agreement – EnglishSpanish
  Controlled Medication Guidelines
  Sleep Medication Client Handout
   
Medication-Assisted Treatment
  Buprenorphine-Naloxone Protocol
  Buprenorphine-Naloxone Patient Information
  Buprenorphine XR Injection Protocol
  Fentanyl Test Strips Instructions
  Naloxone Spray Brochure — Naloxone EnglishNaloxone Spanish
  Narcan vs Kloxxado
  Reduce Heavy Alcohol Use Dosing Recommendations
  Reduce Heavy Alcohol Use Flowchart
  Urge to Drink Scale – EnglishSpanish
  Smoking Cessation Guidelines
  Vivitrol Protocol for AUD
Newer Medications Reviewed by P & T Committee
  Abilify Asimtufii (Aripiprazole LAI)
  Abilify Mycite (Aripiprazole Digital System)
  Aristada (Aripiprazole Lauroxil)
  Aristada Initio (Aripiprazole Lauroxil)
  Auvelity (Dextromethorphan-Bupropion)
  Brixadi (Buprenorphine LAI)
  Caplyta (Lumateperone)
  Cobenfy (Xanomeline and Trospium)
  Dayvigo (Lemborexant)
  Erzofri (Paliperidone Palmitate)
  Fetzima (Levomilnacipran)
  GLP-1 Receptor Agonists
  Hetlioz (Tasimelteon)
  Igalmi (Dexmetetomedine)
  Invega Hafyera (Paliperidone Palmitate)
  Invega Trinza (Paliperidone Palmitate)
  Lybalvi (Olanzapine and Samidorphan)
  Nuplazid (Pimavanserin)
  Onyda XR (Clonidine Extended Release suspension)
  Opipza (Aripiprazole oral film)
  Opvee (Nalmefene)
  Paxlovid Drug Interactions with Psychotropics
  Perseris (Risperidone LAI)
  Qelbree (Viloxazine)
  Quviviq (Daridorexant)
  Rexulti (Brexpiprazole)
  Rykindo (Risperidone Microsphere)
  Secuado (Asenapine Patch)
  Spravato (Ketamine Nasal Spray)
  Sublocade (Buprenorphine LAI)
  Uzedy (Risperidone LAI)
  Trintellix (Vortioxetine)
  VMAT-2 Inhibitors (Austedo, Ingrezza)
  Vraylar (Cariprazine)
  Wakefulness Promoting Agents
  Xelstrym (Dextroamphetamine Transdermal)
  Zulresso (Brexanolone)
  Zursuvae (Zuranolone)
Information Use Only
  BHRS Position Statement on Ketamine
  Ketamine Consensus Statement by APA 2017
  BHRS Position Statement on Medical Marijuana
  BHRS Position Statement on the Use of Psychedelics in Psychiatry
  Compounding Pharmacies
       Psychotropics Available in Liquid or ODT formulations